LONDON: British drugmaker GlaxoSmithKline on Wednesday slashed its 2014 profits forecast as second-quarter earnings sank on the back of weak US trade, adverse currency moves and a Chinese bribery probe.
In a gloomy results statement, GSK said it now expected its earnings per share — a key measure of performance — to be “broadly flat” this year.
Net profit, or profit after tax, dived 37pc to £654 million ($1.11 billion, 827m euros) in the three months to June 30, down from £1.045bn in the same period of last year, GSK added.—AFP
Published in Dawn, July 24th, 2014
Read more
On DawnNews
Dear visitor, the comments section is undergoing an overhaul and will return soon.